Clinical Trial Update: Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating immunochemotherapy and allogeneic stem cell transplantation in high-risk CD33+ acute myeloid leukemia and myelodysplastic synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: New York Medical College | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED